Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes

Hayfaa A Wahabi, Amel Fayed, Samia Esmaeil, Hala Elmorshedy, Maher A Titi, Yasser S Amer, Rasmieh A Alzeidan, Abdulaziz A Alodhayani, Elshazaly Saeed, Khawater H Bahkali, Melissa K Kahili-Heede, Amr Jamal, Yasser Sabr, Hayfaa A Wahabi, Amel Fayed, Samia Esmaeil, Hala Elmorshedy, Maher A Titi, Yasser S Amer, Rasmieh A Alzeidan, Abdulaziz A Alodhayani, Elshazaly Saeed, Khawater H Bahkali, Melissa K Kahili-Heede, Amr Jamal, Yasser Sabr

Abstract

Background: Pre-gestational diabetes mellitus is associated with increased risk of maternal and perinatal adverse outcomes. This systematic review was conducted to evaluate the effectiveness and safety of pre-conception care (PCC) in improving maternal and perinatal outcomes.

Methods: Databases from MEDLINE, EMBASE, WEB OF SCIENCE, and Cochrane Library were searched, including the CENTRAL register of controlled trials, and CINHAL up until March 2019, without any language restrictions, for any pre-pregnancy care aiming at health promotion, glycemic control, and screening and treatment of diabetes complications in women with type I or type II pre-gestational diabetes. Trials and observational studies were included in the review. Newcastle-Ottawa scale and the Cochrane collaboration methodology for data synthesis and analysis were used, along with the GRADE tool to evaluate the body of evidence.

Results: The search identified 8500 potentially relevant citations of which 40 reports of 36 studies were included. The meta-analysis results show that PCC reduced congenital malformations risk by 71%, (Risk ratio (RR) 0.29; 95% CI: 0.21-0.40, 25 studies; 5903 women; high-certainty evidence). The results also show that PCC may lower HbA1c in the first trimester of pregnancy by an average of 1.27% (Mean difference (MD) 1.27; 95% CI: 1.33-1.22; 4927 women; 24 studies, moderate-certainty evidence). Furthermore, the results suggest that PCC may lead to a slight reduction in the risk of preterm delivery of 15%, (RR 0.85; 95% CI: 0.73-0.99; nine studies, 2414 women; moderate-certainty evidence). Moreover, PCC may result in risk reduction of perinatal mortality by 54%, (RR 0.46; 95% CI: 0.30-0.73; ten studies; 3071 women; moderate-certainty evidence). There is uncertainty about the effects of PCC on the early booking for antenatal care (MD 1.31; 95% CI: 1.40-1.23; five studies, 1081 women; very low-certainty evidence) and maternal hypoglycemia in the first trimester, (RR 1.38; 95% CI: 1.07-1.79; three studies; 686 women; very low- certainty evidence). In addition, results of the meta-analysis indicate that PCC may lead to 48% reduction in the risk of small for gestational age (SGA) (RR 0.52; 95% CI: 0.37-0.75; six studies, 2261 women; moderate-certainty evidence). PCC may reduce the risk of neonatal admission to intensive care unit (NICU) by 25% (RR 0.75; 95% CI: 0.67-0.84; four studies; 1322 women; moderate-certainty evidence). However, PCC may have little or no effect in reducing the cesarean section rate (RR 1.02; 95% CI: 0.96-1.07; 14 studies; 3641 women; low-certainty evidence); miscarriage rate (RR 0.86; 95% CI: 0.70-1.06; 11 studies; 2698 women; low-certainty evidence); macrosomia rate (RR 1.06; 95% CI: 0.97-1.15; nine studies; 2787 women, low-certainty evidence); neonatal hypoglycemia (RR 0.93; 95% CI: 0.74-1.18; five studies; 880 women; low-certainty evidence); respiratory distress syndrome (RR 0.78; 95% CI: 0.47-1.29; four studies; 466 women; very low-certainty evidence); or shoulder dystocia (RR 0.28; 95% CI: 0.07-1.12; 2 studies; 530 women; very low-certainty evidence).

Conclusion: PCC for women with pre-gestational type 1 or type 2 diabetes mellitus is effective in improving rates of congenital malformations. In addition, it may improve the risk of preterm delivery and admission to NICU. PCC probably reduces maternal HbA1C in the first trimester of pregnancy, perinatal mortality and SGA. There is uncertainty regarding the effects of PCC on early booking for antenatal care or maternal hypoglycemia during the first trimester of pregnancy. PCC has little or no effect on other maternal and perinatal outcomes.

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1. Process of selection of the…
Fig 1. Process of selection of the studies for the systematic review (PRISMA flow chart).
Fig 2. The mean gestational age at…
Fig 2. The mean gestational age at the time of the first antenatal visit from five studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 3. Risk ratio for congenital malformations…
Fig 3. Risk ratio for congenital malformations from 25 studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 4. First trimester means values of…
Fig 4. First trimester means values of glycosylated hemoglobin (HbA1c) from 24 studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 5. Risk ratio for maternal hypoglycaemia…
Fig 5. Risk ratio for maternal hypoglycaemia from three studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 6. Risk ratio for preterm delivery…
Fig 6. Risk ratio for preterm delivery from nine studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 7. Risk ratio for perinatal mortality…
Fig 7. Risk ratio for perinatal mortality from ten studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 8. Risk ratio for small for…
Fig 8. Risk ratio for small for gestational age from six studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 9. Risk ratio for neonatal intensive…
Fig 9. Risk ratio for neonatal intensive care unit admission from four studies of women with pre-existing diabetes mellitus who did or did not receive preconception care.
Fig 10
Fig 10
Funnel plots for studies included in the meta-analysis for the effect of PCC on congenital anomalies (a), perinatal mortality (b) and HbA1c (c).

References

    1. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels, Belgium: IDF; [15 October 2019]. Available from: .
    1. Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet (London, England). 2010;375(9733):2254–66. Epub 2010/07/09. 10.1016/s0140-6736(10)60550-8 .
    1. Temple R, Aldridge V, Greenwood R, Heyburn P, Sampson M, Stanley K. Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ (Clinical research ed). 2002;325(7375):1275–6. Epub 2002/11/30. 10.1136/bmj.325.7375.1275
    1. Ray JG, Vermeulen MJ, Meier C, Wyatt PR. Risk of congenital anomalies detected during antenatal serum screening in women with pregestational diabetes. QJM: monthly journal of the Association of Physicians. 2004;97(10):651–3. Epub 2004/09/16. 10.1093/qjmed/hch107 .
    1. Wren C, Birrell G, Hawthorne G. Cardiovascular malformations in infants of diabetic mothers. Heart. 2003;89(10):1217–20. 10.1136/heart.89.10.1217 .
    1. Kock K, Kock F, Klein K, Bancher-Todesca D, Helmer H. Diabetes mellitus and the risk of preterm birth with regard to the risk of spontaneous preterm birth. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2010;23(9):1004–8. Epub 2010/01/12. 10.3109/14767050903551392 .
    1. Mathiesen ER, Ringholm L, Damm P. Stillbirth in diabetic pregnancies. Best practice & research Clinical obstetrics & gynaecology. 2011;25(1):105–11. Epub 2011/01/25. 10.1016/j.bpobgyn.2010.11.001 .
    1. Vitoratos N, Vrachnis N, Valsamakis G, Panoulis K, Creatsas G. Perinatal mortality in diabetic pregnancy. Annals of the New York Academy of Sciences. 2010;1205:94–8. Epub 2010/09/16. 10.1111/j.1749-6632.2010.05670.x .
    1. Wahabi HA, Alzeidan RA, Bawazeer GA, Alansari LA, Esmaeil SA. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC pregnancy and childbirth. 2010;10:63 Epub 2010/10/16. 10.1186/1471-2393-10-63
    1. Wender-Ozegowska E, Wroblewska K, Zawiejska A, Pietryga M, Szczapa J, Biczysko R. Threshold values of maternal blood glucose in early diabetic pregnancy—prediction of fetal malformations. Acta obstetricia et gynecologica Scandinavica. 2005;84(1):17–25. Epub 2004/12/18. 10.1111/j.0001-6349.2005.00606.x .
    1. Preconception care of women with diabetes. Diabetes care. 2003;26 Suppl 1:S91–3. Epub 2002/12/28. 10.2337/diacare.26.2007.s91 .
    1. National Collaborating Centre for Ws, Children's H. National Institute for Health and Clinical Excellence: Guidance. Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: RCOG Press. National Collaborating Centre for Women's and Children's Health.; 2008.
    1. Peterson C, Grosse SD, Li R, Sharma AJ, Razzaghi H, Herman WH, et al. Preventable health and cost burden of adverse birth outcomes associated with pregestational diabetes in the United States. American journal of obstetrics and gynecology. 2015;212(1):74e1-9. Epub 2014/12/03. 10.1016/j.ajog.2014.09.009
    1. Murphy HR, Temple RC, Ball VE, Roland JM, Steel S, Zill EHR, et al. Personal experiences of women with diabetes who do not attend pre-pregnancy care. Diabetic medicine: a journal of the British Diabetic Association. 2010;27(1):92–100. Epub 2010/02/04. 10.1111/j.1464-5491.2009.02890.x .
    1. Carrasco Falcon S, Vega Guedes B, Alvarado-Martel D, Wagner AM. Preconception care in diabetes: Predisposing factors and barriers. Endocrinologia, diabetes y nutricion. 2018;65(3):164–71. Epub 2018/01/06. 10.1016/j.endinu.2017.10.014 .
    1. Wahabi HA, Alzeidan RA, Esmaeil SA. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis. BMC public health. 2012;12:792 Epub 2012/09/18. 10.1186/1471-2458-12-792
    1. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ (Clinical research ed). 2008;336(7650):924–6. Epub 2008/04/26. 10.1136/
    1. Wahabi H, Bahkali K, Titi M, Esmaeil S, Amer Y, Fayed A, et al. PROSPERO International prospective register of systematic reviews Preconception care for diabetic women for improving maternal and perinatal outcomes: a systematic review and meta-analysis 2019.
    1. Well GA, Shea B, C’Connell D, Peterson J, Welch V, Losos M, et al. The Newcaslte-Ottawa Scal (NOS) for assessing the quality of non randomised studies in met-analyses. 2005;[].
    1. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane; [updated July 2019]. Available from: .
    1. Schünemann H, Brożek J, Guyatt G, A. O. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach. [updated Updated October 2013; cited August 2019]. Available from: .
    1. GRADEpro GDT: GRADEpro Guideline Development Tool [Software]. McMaster University, 2015. (developed by Evidence Prime, Inc.). Available from .
    1. Review manager (RevMan). Copenhagen (Denmark): The Cochrane Collaboration, Nordic Cochrane Centre; 2014.
    1. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ (Clinical research ed). 2003;327(7414):557 10.1136/bmj.327.7414.557
    1. Hartling L, Hamm M, A M. Validity and Inter-Rater Reliability Testing of Quality Assessment Instruments US: Rockville (MD): Agency for Healthcare Research and Quality (US); 2012. [18 August 2019]. Available from:
    1. M; S, Kaur J, Singh S, Thumburu K, Jaiswal N, A C. Comparison of Newcastle Ottawa scale (NOS) and Agency for Health Research and Quality (AHRQ) as risk of bias assessment tools for cohort studies. Cochrane Colloquium Vienna [Internet]. Vienna: Cochrane Colloquium Abstracts;; 2015 [18 August 2019]. Available from:
    1. Fuhrmann K, Reiher H, Semmler K, Fischer F, Fischer M, Glockner E. Prevention of congenital malformations in infants of insulin-dependent diabetic mothers. Diabetes care. 1983;6:219–23. 10.2337/diacare.6.3.219
    1. Fuhrmann K, Reiher H, Semmler K, Glockner E. The effect of intensified conventional insulin therapy before and during pregnancy on the malformation rate in offspring of diabetic mothers. Experimental and Clinical Endocrinology. 1984;83:173–7. 10.1055/s-0029-1210327
    1. Fuhrmann K. Treatment of pregnant insulin-dependent diabetic women. Acta Endocrinol Suppl (Copenh). 1986;277:74–6.
    1. Temple RC, Aldridge V, Stanley K, Murphy HR. Glycaemic control throughout pregnancy and risk of pre-eclampsia in women with type I diabetes. BJOG. 2006;113:1329–32. 10.1111/j.1471-0528.2006.01071.x
    1. Temple RC, Aldridge VJ, Murphy HR. Prepregnancy care and pregnancy outcomes in women with type 1 diabetes. Diabetes care. 2006;29:1744–9. 10.2337/dc05-2265
    1. Steel JM, Johnstone FD, Smith AF, Duncan LJP. Five years’ experience of “prepregnancy” clinic for insulin-dependent diabetics. BMJ (Clinical research ed). 1982;285:353–6.
    1. Steel JM, Johnstone FD, Hepburn DA, Smith AF. Can prepregnancy care of diabetic women reduce the risk of abnormal babies? BMJ (Clinical research ed). 1990;301:1070–4.
    1. Yamamoto J, Hughes D, Evans M, Karunakaran V, Clark J, Morrish N et al. Community-based pre-pregnancy care programme improves pregnancy preparation in women with pre-gestational diabetes. Diabetologia. 2018;61(7):1528–37. 10.1007/s00125-018-4613-3
    1. Bank W. [cited 2019 July 17, 2019]. Available from: .
    1. Damm P, Molsted-Pedersen L. Significant decrease in congenital malformations in newborn infants of an unselected population of diabetic women. American journal of obstetrics and gynecology. 1989;161:1163–7. 10.1016/0002-9378(89)90656-x
    1. Cousins L. The California Diabetes and Pregnancy Programme: a statewide collaborative programme for the pre-conception and prenatal care of diabetic women. Baillieres Clin Obstet Gynaecol. 1991;5(2):443–59. 10.1016/s0950-3552(05)80106-3
    1. Kitzmiller JL, Gavin LA, Gin GD, Jovanovic-Peterson L, Main EK, Zigrang WD. Preconception care of diabetes. Glycemic control prevents congenital anomalies. JAMA. 1991;265:731–6.
    1. Rosenn B, Miodovnik M, Combs CA, Khoury J, Siddiqi TA. Pre-conceptionmanagement of insulin-dependent diabetes: improvement of pregnancy outcome. Obstet Gynecol. 1991;77:846–9.
    1. Willhoite MB, Bennert Hw Jr, Palomaki GE, Zaremba MM, Herman Wh Williams JR, et al. The impact of preconception counselling on pregnancy outcomes. The experience of the Maine Diabetes in Pregnancy Program. Diabetes care. 1993;16:450–5. 10.2337/diacare.16.2.450
    1. Garcia-Patterson A, Corcoy R, Rigla M, Caballero A, Adelantado JM, Altirriba O. et al.: Does preconceptional counselling in diabetic women influence perinatal outcome? Ann Ist Super Sanita. 1997;33:333–6.
    1. Herman WH, Janz NK, Becker MP, Charron-Prochownik D. Diabetes and pregnancy. Preconception care, pregnancy outcomes, resource utilization and costs. J Reprod Med. 1999;44:33–8.
    1. Jaffiol C, Baccara MT, Renard E, Apostol DJ, Lefebvre P, Boulot P. et al.: [Evaluation of the benefits brought by pregnancy planning in type 1 diabetes mellitus]. Bull Acad Natl Med. 2000;184:995–1007.
    1. Gunton JE, Morris J, Boyce S, Kelso I. Outcome of pregnancy complicated by pre-gestational diabetes improvement in outcomes. Aust N Z J Obstet Gynaecol. 2002;42(5):478-. 10.1111/j.0004-8666.2002.00478.x
    1. Boulot P, Chabbert-Buffet N, d’Ercole C, Floriot M, Fontaine P, Fournier A. et al.: French multicentric survey of outcome of pregnancy in women with pregestational diabetes. Diabetes care. 2003;26:2990–3. 10.2337/diacare.26.11.2990
    1. Hiéronimus S, Cupelli C, Durand-Réville M, Bongain A, Fénichel P. Grossesse et diabète de type 2: quel pronostic fœtal? Pregnancy and type 2 diabetes: which fetal prognosis? Gynécologie Obstétrique & Fertilité. 2004;32(1):23–7.
    1. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ (Clinical research ed). 2004:328:915–328:915.
    1. Galindo A, Burguillo AG, Azriel S, Fuente PL. Outcome of fetuses in women with pregestational diabetes mellitus. J Perinat Med. 2006;34:323–31. 10.1515/JPM.2006.062
    1. Heller S, Damm P, Mersebach H, Skjøth TV, Kaaja R, Hod M, et al. Hypoglycemia in type 1 diabetic pregnancy: role of preconception insulin aspart treatment in a randomized study. Diabetes care. 2010;33(3):473–7. 10.2337/dc09-1605
    1. Egan AM, Danyliv A, Carmody L, Kirwan B, Dunne FP. A Prepregnancy Care Program for Women With Diabetes: Effective and Cost Saving. J Clin Endocrinol Metab. 2016;101(4):1807–15. 10.1210/jc.2015-4046
    1. Holmes VA, Hamill LL, Alderdice FA, Spence M, Harper R, Patterson CC, et al. Women with Diabetes Project Team. Effect of implementation of a preconception counselling resource for women with diabetes: A population based study. Prim Care Diabetes. 2017;11(1):37–45. 10.1016/j.pcd.2016.07.005
    1. Wotherspoon AC, Young IS, Patterson CC, McCance DR, Holmes VA. Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Effect of pregnancy planning on maternal and neonatal outcomes in women with Type 1 diabetes. Diabetic medicine: a journal of the British Diabetic Association. 2017;54(9):1303–8.
    1. Goldman JA, Dicker D, Feldberg D, Yeshaya A, Samuel N, Karp M. Pregnancy outcome in patients with insulin-dependent diabetes control: a comparative study. American journal of obstetrics and gynecology. 1986;155:293–7. 10.1016/0002-9378(86)90812-4
    1. Rowe BR, Rowbotham CJ, Barnett AH. Pre-conception counselling, birth weight, and congenital abnormalities in established and gestational diabetic pregnancy. Diabetes Res. 1987;6:33–5.
    1. Dicker D, Feldberg D, Samuel N, Yeshaya A, Karp M, Goldman JA. Spontaneous abortion in patients with insulin-dependent diabetes mellitus: the effect of preconceptional diabetic control. American journal of obstetrics and gynecology. 1988;158:1161–4. 10.1016/0002-9378(88)90245-1
    1. Dunne FP, Brydon P, Smith T, Essex M, Nicholson H, Dunn J. Preconception diabetes care in insulin-dependent diabetes mellitus. QJM: monthly journal of the Association of Physicians. 1999;92:175–6.
    1. Gunton J E, McElduff A, Sulway M, Stiel J, Kelso I, Boyce S, et al. Outcome of pregnancies complicated bypre-gestational diabetes mellitus. Aust N Z J Obstet. 2000;40(1):38–43.
    1. Cyganek K, Hebda-Szydlo A, Katra B, Skupien J, Klupa T, Janas I, et al. Glycemic control and selected pregnancy outcomes in type 1 diabetes women on continuous subcutaneous insulin infusion and multiple daily injections: the significance of pregnancy planning. DiabetesTechnol Ther. 2010;12(1):41–7.
    1. Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ, et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes care. 2010;33(12):2514–20. 10.2337/dc10-1113
    1. Kallas-Koeman M, Farah Khandwala Lois E Donovan. Rate of Preconception Care in Women with Type 2 Diabetes Still Lags behind that of Women with Type 1 Diabetes. Canadian Journal of Diabetes. 2012;36(4):170–4.
    1. Gutaj P, Zawiejska A, Wender-Ożegowska E, Brązert J. Maternal factors predictive of first‑trimester pregnancy loss in women with pregestational diabetes. Pol Arch Med Wewn. 2013;123(12):21–8.
    1. Wong VW, Suwandarathne H, Russell H. Women with pre-existing diabetes under the care of diabetes specialist prior to pregnancy: are their outcomes better? Aust N Z J Obstet Gynaecol. 2013;53(2):207–10. 10.1111/ajo.12044
    1. Neff KJ, Forde R, Gavin C, Byrne MM, Firth RG, Daly S, et al. Pre-pregnancy care and pregnancy outcomes in type 1 diabetes mellitus: a comparison of continuous subcutaneous insulin infusion and multiple daily injection therapy. Ir J Med Sci. 2014;183(3):397–403. 10.1007/s11845-013-1027-6
    1. Cyganek K, Katra B, Hebda-Szydło A, Janas I, Trznadel-Morawska I, Witek P, et al. Changes in preconception treatment and glycemic control in women with type 1 diabetes mellitus: a 15‑year single‑center follow‑up. Polskie Archiwum MedycynyWewnętrznej. 2016;126:(10)-().
    1. Kekäläinen P, Juuti M, Walle T, Laatikainen T. Pregnancy planning in type 1 diabetic women improves glycemic control and pregnancy outcome. The journal of maternal-fetal & neonatal medicine: the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstet. 2016;29(14):2252–8.
    1. Pregnancy outcomes in the Diabetes Control and Complications Trial. American journal of obstetrics and gynecology. 1996;174(4):1343–53. Epub 1996/04/01. 10.1016/s0002-9378(96)70683-x .
    1. Garcia Ingelmo MT, Herranz dlM, Martin VP, Janez FM, Grande AC, Pallardo Sanchez LF. [Preconceptional control in diabetic women]. Rev Clin Esp. 1998;198:80–4.
    1. Jensen BM, Kuhl C, Molsted-Pedersen L, Saurbrey N, Fog-Pedersen J. Preconceptional treatment with insulin infusion pumps in insulindependent diabetic women with particular reference to prevention of congenital malformations. Acta Endocrinol Suppl (Copenh). 1986;277:81–5.
    1. Terrin N, Schmid CH, Lau J. In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias. Journal of clinical epidemiology. 2005;58(9):894–901. Epub 2005/08/09. 10.1016/j.jclinepi.2005.01.006 .
    1. Wang M, Athayde N, Padmanabhan S, Cheung NW. Causes of stillbirths in diabetic and gestational diabetes pregnancies at a NSW tertiary referral hospital. Aust N Z J Obstet Gynaecol. 2019;59(4):561–6. Epub 2019/01/22. 10.1111/ajo.12936 .
    1. Hoang TT, Marengo LK, Mitchell LE, Canfield MA, Agopian AJ. Original Findings and Updated Meta-Analysis for the Association Between Maternal Diabetes and Risk for Congenital Heart Disease Phenotypes. American journal of epidemiology. 2017;186(1):118–28. Epub 2017/05/16. 10.1093/aje/kwx033
    1. Allen VM, Armson BA. Teratogenicity associated with pre-existing and gestational diabetes. Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC. 2007;29(11):927–34. Epub 2007/11/06. 10.1016/S1701-2163(16)32653-6 .
    1. Oyen N, Diaz LJ, Leirgul E, Boyd HA, Priest J, Mathiesen ER, et al. Prepregnancy Diabetes and Offspring Risk of Congenital Heart Disease: A Nationwide Cohort Study. Circulation. 2016;133(23):2243–53. Epub 2016/05/12. 10.1161/CIRCULATIONAHA.115.017465
    1. Yang P, Reece EA, Wang F, Gabbay-Benziv R. Decoding the oxidative stress hypothesis in diabetic embryopathy through proapoptotic kinase signaling. American journal of obstetrics and gynecology. 2015;212(5):569–79. Epub 2014/12/02. 10.1016/j.ajog.2014.11.036
    1. Evans JL, Goldfine ID, Maddux BA, Grodsky GM. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine reviews. 2002;23(5):599–622. Epub 2002/10/10. 10.1210/er.2001-0039 .
    1. Banhidy F, Dakhlaoui A, Puho EH, Czeizel AA. Is there a reduction of congenital abnormalities in the offspring of diabetic pregnant women after folic acid supplementation? A population-based case-control study. Congenital anomalies. 2011;51(2):80–6. Epub 2010/11/03. 10.1111/j.1741-4520.2010.00302.x .
    1. Wilson RD, Wilson RD, Audibert F, Brock JA, Carroll J, Cartier L, et al. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies. Journal of obstetrics and gynaecology Canada: JOGC = Journal d'obstetrique et gynecologie du Canada: JOGC. 2015;37(6):534–52. Epub 2015/09/04. 10.1016/s1701-2163(15)30230-9 .
    1. Jensen DM, Korsholm L, Ovesen P, Beck-Nielsen H, Moelsted-Pedersen L, Westergaard JG, et al. Peri-conceptional A1C and risk of serious adverse pregnancy outcome in 933 women with type 1 diabetes. Diabetes care. 2009;32(6):1046–8. Epub 2009/03/07. 10.2337/dc08-2061
    1. Nielsen GL, Moller M, Sorensen HT. HbA1c in early diabetic pregnancy and pregnancy outcomes: a Danish population-based cohort study of 573 pregnancies in women with type 1 diabetes. Diabetes care. 2006;29(12):2612–6. Epub 2006/11/30. 10.2337/dc06-0914 .
    1. Gabbay-Benziv R, Reece EA, Wang F, Yang P. Birth defects in pregestational diabetes: Defect range, glycemic threshold and pathogenesis. World journal of diabetes. 2015;6(3):481–8. Epub 2015/04/22. 10.4239/wjd.v6.i3.481
    1. Ludvigsson JF, Neovius M, Soderling J, Gudbjornsdottir S, Svensson AM, Franzen S, et al. Periconception glycaemic control in women with type 1 diabetes and risk of major birth defects: population based cohort study in Sweden. BMJ (Clinical research ed). 2018;362:k2638 Epub 2018/07/07. 10.1136/bmj.k2638 .
    1. Inkster ME, Fahey TP, Donnan PT, Leese GP, Mires GJ, Murphy DJ. Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies. BMC pregnancy and childbirth. 2006;6:30 Epub 2006/11/01. 10.1186/1471-2393-6-30
    1. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet (London, England). 2008;371(9606):75–84. Epub 2008/01/08. 10.1016/s0140-6736(08)60074-4 .
    1. Chawanpaiboon S, Vogel JP, Moller AB, Lumbiganon P, Petzold M, Hogan D, et al. Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. The Lancet Global health. 2019;7(1):e37–e46. Epub 2018/11/06. 10.1016/S2214-109X(18)30451-0
    1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet (London, England). 2008;371(9608):261–9. Epub 2008/01/22. 10.1016/s0140-6736(08)60136-1 .
    1. Araujo BF, Zatti H, Madi JM, Coelho MB, Olmi FB, Canabarro CT. Analysis of neonatal morbidity and mortality in late-preterm newborn infants. Jornal de pediatria. 2012;88(3):259–66. Epub 2012/06/22. 10.2223/jped.2196 .
    1. Bérard A, Le Tiec M, De Vera MA. Study of the costs and morbidities of late-preterm birth. Archives of Disease in Childhood—Fetal and Neonatal Edition. 2012;97(5):F329 10.1136/fetalneonatal-2011-300969
    1. Malik S, Cleves MA, Zhao W, Correa A, Hobbs CA. Association between congenital heart defects and small for gestational age. Pediatrics. 2007;119(4):e976–82. Epub 2007/03/28. 10.1542/peds.2006-2742 .
    1. Janchevska A, Gucev Z, Tasevska-Rmus L, Tasic V. Congenital Anomalies of the Kidney and Urinary Tract in Children Born Small for Gestational Age. Prilozi (Makedonska akademija na naukite i umetnostite Oddelenie za medicinski nauki). 2017;38(1):53–7. Epub 2017/06/09. 10.1515/prilozi-2017-0007 .
    1. Teixeira MP, Queiroga TP, Mesquita MD. Frequency and risk factors for the birth of small-for-gestational-age newborns in a public maternity hospital. Einstein (Sao Paulo, Brazil). 2016;14(3):317–23. Epub 2016/10/21. 10.1590/s1679-45082016ao3684
    1. Wellings K, Jones KG, Mercer CH, Tanton C, Clifton S, Datta J, et al. The prevalence of unplanned pregnancy and associated factors in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3). Lancet (London, England). 2013;382(9907):1807–16. Epub 2013/11/26. 10.1016/S0140-6736(13)62071-1 .
    1. Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84(5):478–85. Epub 2011/10/25. 10.1016/j.contraception.2011.07.013
    1. Holing EV, Beyer CS, Brown ZA, Connell FA. Why don't women with diabetes plan their pregnancies? Diabetes care. 1998;21(6):889–95. Epub 1998/06/06. 10.2337/diacare.21.6.889 .
    1. Janz NK, Herman WH, Becker MP, Charron-Prochownik D, Shayna VL, Lesnick TG, et al. Diabetes and pregnancy. Factors associated with seeking pre-conception care. Diabetes care. 1995;18(2):157–65. Epub 1995/02/01. 10.2337/diacare.18.2.157 .
    1. Forde R, Patelarou EE, Forbes A. The experiences of prepregnancy care for women with type 2 diabetes mellitus: a meta-synthesis. International journal of women's health. 2016;8:691–703. Epub 2016/12/21. 10.2147/IJWH.S115955

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner